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ABSTRACT
Human African trypanosomiasis (HAT) is a lethal disease caused by protozoan
hemoflagellates of the genus Trypanosoma. Humans are vulnerable to two subspecies,
Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. At the crux of
HAT lethality lie two uncommon genetic expression phenomena: monoallelic expression
and antigenic variation. Combined, these mechanisms effectively shield trypanosomes
from host immune systems, prolonging infections. Variant Surface Glycoproteins (VSGs)
are the key outer membrane proteins involved in antigenic variation. By continuously
changing the composition of cell surface antigens, trypanosomes can survive bouts of
immunological detection and eventually traverse the blood-brain barrier. There are over
two thousand VSG variants within the trypanosome genome, but only one is expressed at
a time. Transcription of the active VSG is initiated by the Class I Transcription Factor A
(CITFA) complex. This basal promoter-binding complex is composed of eight subunits:
CITFA1-7 and dynein light chain LC8. Preliminary data suggested that CITFA7
dimerizes via LC8 and is important for expression of only a single VSG at a time. Results
of a co-immunoprecipitation assay provide evidence against the possibility that CITFA7
dimerizes in vivo, while semi-quantitative and quantitative reverse-transcription PCR data
support the hypothesis that CITFA7 contributes to monoallelic expression. Visualization
of silent VSG derepression with indirect immunofluorescence was attempted to see
whether disruption of monoallelic expression by the expression of a non-lethal mutation
in CITFA7 alters the normally punctuated location of the CITFA complex within the
nucleus. Results from this effort lay the groundwork for future quantitative analysis with
direct fluorescence.
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INTRODUCTION
Trypanosomatids, early diverged parasites of the order Kinetoplastida, give rise to
a number of diseases including sleeping sickness, Chagas disease, and leishmaniasis.
Trypanosoma brucei is a species within this order that is responsible for sleeping
sickness, and nagana in cattle (or human African trypanosomiasis (HAT) and animal
trypanosomiasis, respectively). Humans are vulnerable to two out of the three T. brucei
subspecies. Trypanosoma brucei gambiense leads to a more chronic condition that
prevails throughout central and western Africa, whereas Trypanosoma brucei rhodesiense
leads to a more acute condition that is currently restricted to Uganda (WHO, 2022).
Trypanosoma brucei brucei, the third subspecies, causes animal trypanosomiasis and
poses minimal risk to humans due to its susceptibility to the trypanolytic factor of the
human innate immune system (Radwanska et al., 2018). Thus, T. b. brucei can be utilized
in the laboratory as a relatively safe proxy for studying gene expression in the humaninfectious subspecies.
Research efforts have not yet amounted to an antiparasitic vaccine against HAT.
However, cases of HAT have plummeted to as low as 663 cases in 2020 due to largescale efforts to control vector spread and to diagnose and treat active cases in the early
stages of the disease (CDC, 2019; Tikhonenkov et al., 2021). Despite these strides in
containment, the disease still disproportionately affects people living in remote and
impoverished areas with limited access to healthcare (WHO, 2022). Thus, the search for
potential drug targets and vaccine design remain important efforts that could potentially
also elucidate effective treatment strategies for related diseases.
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Trypanosomes are transmitted by the tsetse fly and undergo eight morphological
transitions that prepare them for the different environments they encounter over the
course of their life cycle. When a tsetse fly bites an infected mammal, trypanosomes
collect in the fly’s midgut where they morph into their mitotically dividing procyclic
form, and subsequently migrate to the fly’s salivary glands as epimastigotes where they
differentiate into non-proliferative metacyclic trypomastigotes. Following a blood meal,
when metacyclics are transferred from the fly to the host, they often remain subcutaneous
for several weeks, causing a skin chancre to form. Once they break into the bloodstream,
metacyclics transition into their slender form (CDC, 2019; Horn, 2014; Ginger, 2002). At
each of these life cycle stages, trypanosomes undergo differentiation which entails
changes in morphology, nutrient-specific metabolism, organelle structure and
organization, and epigenetic regulation of gene transcription to keep up with the specific
challenges posed by each new environment. Consequently, the composition of cell
surface proteins changes distinctly at each stage (Fenn et al., 2007; Quintana et al., 2021;
Briggs et al., 2021).
As procyclics, trypanosomes express procyclins (or procyclic acidic repetitive
protein) on their cell surface, while as metacyclics, trypanosomes monoallelically express
metacyclic variant surface glycoproteins (mVSGs) as a preadaptation to mammalian
blood. Up to seven days after entering the bloodstream of a host, mVSG transcription is
silenced and replaced by monoallelic VSG expression. Both mVSGs and VSGs are
transcribed and processed into functional mRNA through Spliced Leader (SL) transsplicing (Ginger et al., 2002; Günzl, 2010). Most VSG genes are located in subtelomeric
regions of chromosomes or harbored within minichromosomes as functional or pseudo-
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VSGs. However, there are only fifteen VSGs in 427 strain trypanosomes contained within
telomeric domains called bloodstream expression sites (BES), and it is only one BES
VSG that is actively transcribed at a time. Monoallelic VSG expression results in a
uniform cell surface coat, and VSG makes up an impressive 10% of all cell proteins
expressed by slender forms at any given time (Van der Ploeg et al., 1982). Restriction of
expression to a single gene variant is not unique to trypanosomes. In fact, genes encoding
olfactory receptors and immunoglobulin genes have been found to exhibit monoallelic
expression (Schultz and Papavasiliou, 2016; Monahan et al., 2015; Vettermann and
Schlissel, 2010). However, for T. brucei and other infectious organisms such as the
malaria-causing Plasmodium falciparum, monoallelic expression confers a particular
adaptive advantage. By systematically altering the identity of their antigens through the
process of antigenic variation, these parasites can evade detection by host immune
systems, making them particularly pervasive and persistent in their hosts (Turner, 1984).
Teasing apart the different molecular players that regulate monoallelic expression in
these organisms is critical to understanding their pathogenesis and developing effective
treatments against their associated diseases.
Monoallelic expression and antigenic variation work hand in hand. In P.
falciparum, the var gene family—which encodes the adhesion surface molecule
Erythrocyte Membrane Protein 1—is silenced by default, and one var gene is selectively
activated early during the parasite’s development in its host’s blood. Although switching
events of var gene variants are well characterized and essential to the parasite’s survival,
the molecular mechanisms of these events are still under investigation (Deitsch et al.,
2017). Similarly, in T. brucei, monoallelic activation of VSG transcription occurs early in
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development to prepare for the host’s bloodstream, but unlike for P. falciparum, the
mechanism underlying switching events have been investigated at length (Horn, 2014;
Mugnier et al., 2015; Morrison et al., 2009). The three most common types of VSG
switching events in T. brucei occur through gene conversion, telomere exchange, and
transcriptional switching. In the former two cases, the VSG coat is changed through
genetic recombination during meiotic division in the metacyclic and bloodstream stages
whereby a VSG contained within a silent BES, a subtelomeric region, or a
minichromosome replaces the VSG in an active BES. In the latter case, active VSGs
undergo rare epigenetic switching events that lead to the monoallelic expression of a
different VSG (Dreesen et al., 2006). Transcriptional switching is particularly useful in
chronic infections; while trypanosomes expressing a particular VSG may trigger their
host’s adaptive immune response such that they are recognized by antibodies, other
trypanosomes having randomly switched VSG expression may live on and proliferate
because the host has not yet produced antibodies specific against the new VSG (Horn,
2014; Hertz-Fowler et al., 2008).
T. brucei has many unique features, including an unusual mode of transcription.
Whereas in P. falciparum, var genes are transcribed by RNA polymerase II (RNA pol II)
and rRNA is transcribed by RNA pol I, as in all other eukaryotes, T. brucei possesses a
unique RNA pol I that is recruited to both rRNA promoters in the nucleolus as well as to
promoters upstream of procyclin and VSG genes (Günzl et al., 2003). The active VSG
gene is always located within a telomeric BES, which contains several expression site–
associated genes (ESAGs) and a single VSG gene just upstream of the telomeric repeats
(Figure 1). T. brucei Lister 427 cells, the strain used in this study, possesses exactly
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fifteen BESs (Hertz-Fowler et al., 2008). Transcription of a single VSG from the active
BES always occurs within a sub-nucleolar compartment called the expression site body
(ESB), the formation of which is attributed to the trypanosome-specific exclusion protein
VEX1 (Navarro and Gull, 2001; Faria et al., 2019).
BES repression occurs through telomeric silencing, accomplished, in part, by the
telomere-binding protein RAP1 and the histone methyltransferase DOT1B (Figueiredo et
al., 2008; Yang et al., 2009). Silencing almost completely prevents transcription of the
downstream VSG gene but still allows for some transcriptional activity at the repressed
BES promoter lying 50-70 Kb upstream of the telomeric repeats. (Hertz-Fowler et al.,
2008). Interestingly, transcriptional activity occurring at BESs gradually decreases along
its length such that promoter proximal regions are transcribed at levels far higher than
telomere proximal regions. In one model of this phenomenon, the recruitment of histone
modifying enzymes by telomeric proteins spreads repressive chromatin inwards to
diminish transcription elongation along silent BESs (Yang et al., 2009; Wang et al.,
2010). In one study, when the RAP1 gene was knocked down, silent BESs became derepressed but the activity levels of these BESs remained magnitudes below that of the
active BES, suggesting that there is a separate, dedicated mechanism for transcription
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initiation at BESs (Yang et al., 2009).

Figure 1 Schematic of active and silent bloodstream expression sites in T. brucei. Image (not
to scale) shows RNA pol I, CITFA complex, promoter (P), ESAGs (Expression Site Associated Genes), 70
base pair repeats, VSG (variant surface glycoprotein), and telomeric repeats. Proteins associated with the
active BES include SUMO (small ubiquitin-like modifier that positively regulates monoallelic expression
by post-translational modification (Ye et al., 2015; Saura et al., 2019)), TDP1 (essential high-mobilitygroup
box protein that facilitates RNA pol I transcription and is abundant in the nucleolus and ESB (Narayanan et
al., 2013)) and VEX1 (RNA pol I-dependent-VSG exclusion protein which assembles with VEX2 to
sustain the ESB (Glover et al., 2016)). Proteins associated with BES repression include ISWI (members of
the ISWI chromatin-remodeling family are involved in BES downregulation in promoter-proximal regions
(Hughes et al., 2007)), FACT (may reassemble nucleosomes behind RNA pol I as it elongates, repressing
VSG transcription (Denninger, & Rudenko, 2014)), H1 (inhibits RNA pol I transcription (Pena et al.,
2014)), DOT1B (chromatin-modifying enzyme required for complete BES silencing (Figueiredo et al.,
2008)), and RAP1 (an intrinsic component of the T. brucei telomere complex that is essential for complete
silencing of BESs (Yang et al., 2009).
Despite what is known about VSG expression, regulation of BES transcription
activation remains particularly elusive. Characterization of the CITFA complex provided
an important line of evidence that there is a distinct activation mechanism of monoallelic
transcription. CITFA is composed of subunits CITFA1-7 as well as the highly conserved
dimerizing protein, dynein light chain LC8 (Nguyen et al., 2012). CITFA directly binds
to BES and rRNA gene promoters and is essential for RNA pol I to initiate transcription
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(Brandenburg et al., 2007). When CITFA subunit genes were completely ablated,
transcription of rRNA genes and VSG plummeted and cells died within two days,
demonstrating the importance of CITFA for cell viability (Nguyen et al., 2012).
Surprisingly, chromatin immunoprecipitation (ChIP) of either subunits CITFA7 or
CITFA2 revealed that CITFA occupied the promoter of the active BES promoter several
fold more than the promoter of a repressed BES, a phenotype that prevailed even after
trypanosomes had switched consecutively between the two BESs. Since a genome-wide
ChIP-seq analysis ruled out the possibility of CITFA being enriched at the active BES
through stable interaction with transcribing RNA pol I, this finding strongly indicated
that BES activation involves a distinct promoter-centered mechanism dependent on
CITFA (Günzl et al., 2015; Nguyen et al., 2014).
CITFA subunits have been found to be highly enriched in the ESB and the
nucleolus, and not detectable in other parts of the nucleus where silent BESs are located
(Nguyen et al., 2014; Nguyen et al., 2012). This localization pattern was found to remain
intact even after CITFA1, a DNA-binding subunit of CITFA, was silenced. A subsequent
immunoblot assessment of the relative abundances of other CITFA subunits, including
CITFA2, CITFA6, and CITFA7 following CITFA1 silencing showed negligible
reductions in these other subunits, indicating that CITFA1 is not essential for CITFA
complex assembly. Furthermore, indirect immunofluorescence of CITFA3 after CITFA1
silencing showed CITFA3 within the presumed ESB. Given that CITFA1 binds directly
to the BES promoter, yet CITFA3 remained within the ESB when CITFA1 was depleted,
this suggests that CITFA subunits are sequestered within the ESB independent of
transcription initiation at the promoter (Park et al., 2014). In light of this later finding, an
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earlier study found that when trypanosomes were forced to simultaneously express two
mutant BESs containing different antibiotic resistance genes, RNA fluorescence in situ
hybridization resulted in an image of two fluorescent spots very close together and with
diminished fluorescence (Chaves et al., 1999). This finding now seems to suggest that a
key factor(s) involved in BES activation is localized within the ESB, and when two BES
are forcibly co-expressed, competition arises for this limiting factor(s), perhaps the factor
being CITFA.
Published data from our laboratory has shown that CITFA7 is not directly
required for RNA pol I transcription in vitro, nor assembly and integrity of the CITFA
complex (Nguyen et al., 2014; Brandenburg et al., 2007; Nguyen et al., 2012). Yet,
unpublished results from a knockdown of CITFA7 showed an increase in the expression
of repressed BESs severalfold. Further preliminary data suggested that this function of
CITFA7 may require LC8-mediated dimerization. Employing yeast-two-hybrid
technology, our laboratory found evidence that CITFA2 and CITFA7 interact with the
dimerizing protein LC8 and identified in both putative binding sites for LC8 similar to
sites found in human and yeast genes (A. Günzl lab, unpublished). While an anti-CITFA7
antibody did not interfere with VSG transcription in vitro, the same assay with an
antibody against CITFA2 abolished transcription, consistent with the understanding that
dimerized CITFA2 enables the CITFA complex to recognize and bind to BES promoters,
while CITFA7 does not affect promoter binding (Nguyen et al., 2012). Furthermore,
LC8-mediated dimerization of CITFA2 proved essential for CITFA to bind to the BES
promoter, indicating that only dimerized CITFA2 could stably interact with the promoter
(Kirkham, et al., 2017). Although LC8-mediated dimerization of CITFA7 was not
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rigorously verified, the hypothesis emerged that it could also be required for BES
activation, however, not through direct binding to DNA but perhaps instead through an
interaction with a scaffold protein, leading to sequestration of the complex within the
ESB. Based on initial semi-quantitative PCR results, trypanosomes with an LC8 binding
site mutation in CITFA7 exhibited elevated expression of VSG mRNA from a silent BES
(T. Nguyen & A. Günzl, unpublished). Given this preliminary evidence, the goal of this
study was to confirm CITFA7 dimerization in vivo and to determine whether a non-lethal
mutation in CITFA7 could disrupt the localization of the CITFA complex and therefore
monoallelic expression. At present, researchers in this subject are primarily focused on
telomeric silencing as the main mechanism underlying monoallelic VSG expression,
overlooking the essential role of a dedicated, promoter-centered activation mechanism.
This study provides further evidence that BES activation by CITFA7-mediated
sequestration restricts VSG expression to a single allele.
METHODS
Cell Lines and Gene Silencing
For detection of CITFA7 by indirect immunofluorescence and for efficient
pulldown in co-immunoprecipitation, a modified T. brucei brucei strain 427 containing a
tagged copy of CITFA7 was used (Cross, 1975). More specifically, the composite ̴20
kDa PTP tag had been C-terminally fused to CITFA7 and contained a Protein C epitope,
a TEV protease cleavage site, and tandem Protein A domains (ProtA) by methods
described previously (Schimanski, 2005). For CITFA7 silencing, so-called single marker
bloodstream trypanosomes, which express both T7 RNA pol and the tetracycline
repressor, had been stably transfected with a linearized plasmid that contained 500 b.p. of
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CITFA7 3’ untranslated region (UTR) in a sense-loop-antisense arrangement under the
control of the TET-regulated T7 promoter (Wirtz et al., 1999). In a subsequent
transfection, a linearized plasmid was targeted for integration into one of the two CITFA7
alleles to add the PTP tag sequence to the 3’end of the coding region. The plasmid either
left the coding region unchanged (WT cell line) or replaced 269’GTGCAAGTTGAGTGG-283’ (encoding VQVEW) with GCAGCTGCAGCTGCC
(encoding AAAAA). Wildtype (WT) and mutant cell lines expressing PTP-tagged
CITFA7 were independently derived clonal cell lines from the same transfection (WT,
Mut1, MutX). The mutant CITFA7-PTP is therefore identical in Mut1 and MutX clones.
Specific knockdown of the endogenous copy of CITFA7 was achieved by treatment with
doxycycline (dox) (2 µg/mL) for 3 days (3d) or 10 days (10d) which induced the
expression of a hairpin RNA that targeted the 3’ UTR of the endogenous CITFA7 mRNA
via an RNAi pathway, while not affecting CITFA7-PTP mRNA containing a different 3/
UTR (Nguyen et al., 2012).
Cell Culturing
Bloodstream form (BSF) trypanosome cultures were grown at 37°C, 5% PCO2 in
HMI-9 medium (as described by Hirumi and Hirumi, 1989) supplemented with 10% fetal
bovine serum. To maintain genetic modifications, cells were grown in the presence of 2
µg/mL blasticidin, 2.5 µg/mL G418, and 1 µg/mL phleomycin. 10 mL cultures were
grown in a 50 mL flat-bottom, filter-cap flask to a density of 2x10⁶ cells/mL before
splitting or harvesting.
Protein analysis
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Co-IP assays were carried out to assess CITFA7 dimerization in vivo by an
established method (Park et al., 2012). For protein extraction, WT, Mut1, and MutX cells
were grown to a density of 2 x10⁶ cells/mL in 350 mL HMI-9 medium per cell line. Cells
were harvested by centrifugation at 2,700 g, 4°C, for 10 minutes, and resuspended and
washed three times in ice-cold trypanosome wash solution (100 mM NaCl, 3 mM MgCl₂,
and 20 mM of Tris-HCl at pH 7.5). Cells were then resuspended in extraction (E) buffer
(150 mM sucrose, 20 mM L-glutamic acid, 20 mM HEPES-KOH at pH 7.7, and 3mM
MgCl₂), vortexed and centrifuged at 2,700 g, 4°C, for 10 minutes, and resuspended in one
packed-cell-volume of E buffer. 1 mM DTT, 10 µg/mL aprotinin, 10 µg/mL leupeptin,
20 µL phosphatase inhibitor cocktail 2 (Sigma), and ̴200 µL of 800 µm pre-equilibrated
Low Binding Silica Beads (OPS Diagnostics, LLC) were added to the suspended cells,
which were then subjected to five rounds of a vortex-ice incubation-vortex treatment
(shock frozen in liquid nitrogen, immediately hand-thawed). 20 µL of broken cell
suspension was combined with SDS sample buffer (dH₂O, SDS, 200mM βME) up to 2X
to be the input (Inp) sample, and the remaining extract was spun down at 25,000 g 4°C,
and shock frozen in liquid nitrogen.
For precipitation of CITFA7-PTP, 25 μL of settled human IgG beads (GE
Healthcare) were equilibrated and washed 3 times with 800 μL of TET150 buffer
(containing 150 NaCl, 20 mM Tris-HCl at pH 8, 3 mM MgCl2 and 0.1% Tween 20).
Extract was mixed with 50 µL of TET150-suspended beads and chilled in a cool chamber
at 3°C for 1 hour, inverting frequently to facilitate antibody-antigen binding between the
ProtA domain of the PTP tag and the Fc domain of the IgG antibody. Extract was
subsequently centrifuged at 3,000 g for 30 seconds, after which the supernatant (SN)
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sample was collected, and SDS sample buffer was added up to 2X. Bound beads were
washed six times with 800 μL of TET150 buffer (150 mM NaCl, 20 mM Tris–HCl, pH
8.0, 3 mM MgCl₂, 0.1% Tween 20), and CITFA7-PTP was eluted with 80 µL SDS
sample buffer, into which CITFA7-PTP was directly released. 20 μL of samples (2X Inp,
2X SN, 3.5X P) were boiled for 5 minutes and loaded into a 6% stacking-15% separating
SDS-polyacrylamide gel along with a 1X SDS buffer control sample and run at 80
minutes through the stacking gel and then at 120 V through the separating gel over 1 hour
20 minutes. Separated proteins were electroblotted onto a polyvinylidene difluoride
membrane for 1 hour at 100 V at 20°C, which was stored in 1X TBS at 4°C overnight.
To visualize proteins by immunoblotting, the membrane was blocked in 5% milk
blocking solution (2.5 g non-fat dry milk, 50 mL 1X TBST), and stripped with 0.5 M
NaOH for 6 minutes before reprobing. Endogenous CITFA7 was detected with purified
polyclonal ɑ-rat anti-CITFA7 antibody (1:1000), the ProtA domain of CITFA7-PTP was
detected directly with peroxidase anti-peroxidase (PAP) complex (1:5000), the negative
control, CRK9, was detected with purified polyclonal ɑ-rat anti-CRK9 antibody (1:1000),
and the positive control, CITFA6, was detected with purified polyclonal ɑ-rat antiCITFA6 antibody (1:2500). Primary antibodies were detected with anti-rat IgG POD
secondary antibody (1:5000). BM Chemiluminescence Western Blotting Kit (Sigma
Aldrich) was used to detect the peroxidase-labeled secondary antibody and the
chemiluminescent substrate luminol for imaging.
RNA analysis
To qualitatively assess relative VSG mRNA abundance produced from active and
silent BESs, RNA was isolated from trypanosomes growing in exponential phase before
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and after 3d and 10d dox inductions. 10 mL cultures were centrifuged at 2,000 g, 4°C, for
7 minutes, and cells were resuspended in 700 µL of TRIzol™ Reagent (Invitrogen),
vortexed vigorously for 10 seconds and stored overnight at -80°C. Samples were thawed
for 5 minutes at room temperature (RT). 200 µL of chloroform was added, the samples
were again vortexed and incubated for 2 minutes at RT, and centrifuged at 12,000 g, 4°C,
for 15 minutes. The aqueous phase was transferred to a new tube and 500 µL of
isopropanol was added and centrifuged at 12,000 g, 4°C, for 10 minutes. The pellet was
washed with 900 µL of 70% ethanol, and centrifuged at 12,000 g, 4°C, for 5 minutes.
After drying for approximately 10 minutes, the pellet was resuspended in 30 μL of dH₂O.
To avoid PCR amplification of genomic DNA contaminations, a DNA digest was
performed on isolated RNA prior to cDNA synthesis following the standard protocol
(Sigma-Aldrich). RNA was reversed transcribed by SuperScript IV Reverse Transcriptase
with Oligo-dT or random hexamer primers to make cDNA. To assess the quality of the
RNA and to see if there were discrepancies in the relative concentrations between RNA
samples, RNA gel electrophoresis was performed using a ReliantTM Gel System (Lonza).
2 μg of RNA was added to 8 μL of Ambion Glyoxal Sample Loading Dye and incubated
at 50°C for 30 minutes. The samples were spun briefly and placed on ice before loading.
The gel was run in 1X MOPS at 70V (10X MOPS: 200 mM MOPS, 50 mM Sodium
acetate, 10 mM EDTA at pH 7.0) through a precast 1.25% SeaKem Gold agarose RNA
gel, incubated on a shaker in a mixture of 100 mL DMPC with 1 μg/mL ethidium
bromide in a plastic container, and covered in polyvinyl-chloride wrap for 30 minutes.
The gel then was washed 3 times in milli-Q water and imaged in a transilluminator.

Platt 15

For standard RT-PCR of CITFA7, a 4% agarose gel was successful at resolving
the small, amplified cDNA product. A PstI restriction enzyme digest was performed on
amplified cDNA using NEBuffer™ r3.1 according to standard protocol (NEB).
For semi-RT-qPCR, Tₘ was calculated for each primer to optimize the annealing
temperatures, and primer length taken into account when selecting extension times. The
linear range of product increase was found to be 29 cycles for cDNA of silent VSGs.
For RT-qPCR, melting curves and standard curves were analyzed before
calculating relative mRNA abundance from cycle threshold (Cₜ) values using the DeltaDelta-Cₜ Method (Livak and Schmittgen, 2001). SYBR Green I dye was used in RTqPCR reactions to obtain Cₜ values, and these values for VSG sequences were normalized
against those Cₜ values of ɑ-tubulin which is expressed at high levels like the active VSG
and is transcribed by RNA pol II.
DNAs
DNA oligonucleotides specific to the coding sequence of CITFA7 used for RTPCR have been previously described (Park et. al., 2014). Oligonucleotides used for semiRT-qPCR and RT-qPCR included the following: 5’-AGTTTCTTAGCAACTGACTGC3’and 5’-CACCTACGTTTTCGAGCTGT-3’ for the single silent VSG mRNA (dubbed
VSGbR2), 5’-AAATGGGAGGGTRAAACTTGCAAAG-3’ and 5’CAAGGCCACAAATGCAGCAG-3’ for consensus oligonucleotides for four BESlocalized silent VSGs mRNA, 5’-AGCTTTTTGGCAACCTCTTTGCCAGG-3’ and 5’CCTTATCGACCGTTTTGTCCGCAATGGT-3’ for the active VSG mRNA (dubbed
VSG221), 5’-GTGCATTGAACGTGGATCTG-3’ and 5’CGGATGGTGCTCGTTACGTG-3’ for ɑ-tubulin, and 5’-

Platt 16

TCATCAAACTGTGCCGATTAC-3’and 5’-CTATTGAAGCAATATCGG-3’ for the
18S rRNA coding region.
Indirect immunofluorescence
Localization of CITFA7 within the nucleus was examined through an established
indirect immunofluorescence method (Nguyen et al., 2012). Coverslips were washed in
acetone and silanized with 2% aminopropyltriethoxysilane for 1 minute on a shaker. BSF
cells were grown to exponential phase and harvested at a density of 2 x 10⁶ cells/mL. 10
mL of each cell culture were spun at 800 g for five minutes at RT, washed in 1X PBS,
and fixed with a final concentration of 2% formaldehyde for 10 minutes at RT. Fixation
was terminated by adding glycine to a final concentration of 0.125 M and incubating for
5 minutes at RT. Cells were then washed three times and resuspended in 1X PBS to a
density of 3.5 x 10⁶ cells/mL, and 250 μL were spotted on silanized coverslips and left to
settle for 30 minutes. Unadhered cells were gently washed away twice with 1X PBS for
5 minutes each and fixed cells were stored at 4°C overnight. Fixe cells were then placed
in a circular 6-well plate and spun at 800 g for 2 minutes at RT, and rehydrated in 1X
PBS for 10 minutes, permeabilized with 0.1% NP40 in 1X PBS for exactly 5 minutes,
washed twice in 1 mL 1X PBS, and washed once with 500 μL PBG (1X phosphatebuffered saline (PBS), 0.2% fish gelatin and 0.5% BSA) for 5 minutes each. The cells
were blocked twice in 250 μL PBG for 10 minutes and incubated with primary ɑ-rabbit
anti-ProtA antibody (1:40,000 dilution in 1X PBG) for 1.5 hours at RT. After washing six
times on shaker in 1X PBS containing 0.05% Tween 20, slips were incubated with
secondary Alexa Fluor™ 594 antibody (Thermo Fisher; 1:400 dilution in 1X PBG) along
with DAPI (1:200) in 1X PBG for 45 minutes with a foil covering to prevent fluorophore
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bleaching. The slips were washed six times in 1X PBS on a shaker to remove unbound
antibodies and mounted onto a slide with 7 μL Vectashield per slip. Cells were visualized
and imaged with a Zeiss 780 Upright Confocal microscope equipped with a 63X
objective and a 561 nm Diode laser. Exposure time was adjusted to optimize the
detection of nuclear fluorescent signals. Images were analyzed in Fiji-ImageJ and
brightness and contrast were adjusted for better visualization.
RESULTS
Mutation in the putative LC8 binding site of CITFA7 is nonlethal. Previously, a
sedimentation analysis strongly indicated that subunit CITFA2 dimerizes through an
interaction with LC8 (Kirkham et al., 2016). Results of a subsequent yeast-two-hybrid
analysis suggested that CITFA7, in addition to CITFA2, dimerizes in vitro. Given
CITFA2’s interaction with LC8, it was thought that CITFA7 might also dimerize via
LC8. Using an LC8 binding partner prediction system (Rapali et al., 2011), the 89’GVQVEW-94’ motif within CITFA7 was identified as the potential LC8 binding site (J.
Kirkham, unpublished).
To elucidate whether CITFA7 does, in fact, dimerize in vivo, 427 strain BSF
trypanosomes were modified to express a PTP-tagged version of CITFA7 from one allele
while leaving the remaining CITFA7 allele unmodified. A mutation was then introduced
into clones of the CITFA7-PTP-expressing cell lines such that five amino acids in the
putative LC8 binding site were replaced with five alanines. Because all cells derived from
a parent line expressing a T7 RNA pol and bacterial tetracycline (TET) repressor,
silencing of the endogenous copy of CITFA7 could be reversibly induced in the presence
of doxycycline, a more stable derivative of tetracycline (Figure 2A).
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CITFA7 has been found to be essential for cell viability—when CITFA7 was
silenced, transcription of RNA pol I-transcribed genes plummeted and cells died (Nguyen
et al., 2012). However, silencing of the endogenous CITFA7 in mutant clones expressing
CITFA7-PTP did not lead to a decline in cell growth over 3d and 10d inductions,
confirming that the CITFA7 mutation is nonlethal (Figure 2B; growth curve for 10d not
shown). To check that both wild type and mutant cells were, in fact, expressing CITFA7PTP, standard PCR was performed. Based on the fact that only the mutant CITFA7-PTP
sequence contains a PstI restriction site, this sequence difference was leveraged to
confirm the expression of the mutant gene in mutant cells after 10d induction. Gel
electrophoresis results show fragmented PCR-amplified DNA from cDNA of mutant
CITFA7-PTP in the mutant lane following PstI digest, whereas only unfragmented cDNA
appear in the WT lane, as expected (Figure 2C).
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Figure 2 Verification of non-lethality and expression of mutant CITFA7. (A) Schematic of the
CITFA7 locus in smC7PTP-WT or -Mut1 or -MutX cells expressing CITFA7-PTP from one allele (not to
scale). (B) Growth curve of representative WT, Mut1 and MutX cells over 3d induction, silencing
endogenous CITFA7 (counts performed by A. Günzl). (C) Before (left) and after (right) restriction enzyme
digest with PstI performed on CITFA7-PTP PCR products.

CITFA7 likely does not dimerize in vivo. To test for dimerization of CITFA7 in vivo,
co-IP was carried out against the PTP tag in CITFA7-PTP with CITFA7-PTP-WT protein
extracts, and results were assessed with an immunoblot. If dimerization occurred, it
would be expected that pulldown of CITFA7-PTP would co-precipitate untagged
CITFA7, leaving little CITFA7 in the supernatant and the majority in the pellet sample.
As expected, the negative control, cyclin-dependent kinase CRK9, was detected in the
input and supernatant sample lanes, but not in the pellet sample lane. Conversely, the
positive control, CITFA6, was detected in the input and pellet lanes, but only faintly
detectable in the supernatant, indicating successful co-precipitation with CITFA7-PTP
(Figure 3, top panel). Likewise, the PTP tag of CITFA7-PTP was visualized clearly in the
input and pellet lanes and was depleted from the supernatant sample. When the
immunoblot was reprobed with anti-CITFA7 antibody, the protein was successfully
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detected in the input lane, as expected. However, counter to the hypothesis, CITFA7 did
not appear to co-precipitate with CITFA7-PTP, as it was both clearly detected in the
supernatant lane and virtually absent in pellet lane, opposite to expectations (Figure 3).
These results suggest that CITFA7 may not dimerize in vivo. However, there is also the
possibility that the CITFA7-LC8 interaction did not withstand co-IP, given that different
LC8 binding sites have different affinities for LC8 (Rapali et al., 2011; Jespersen et al.,
2019).
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Figure 3 Immunoblot testing for CITFA7 dimerization. CITFA7-PTP was precipitated from extract
with IgG beads, and proteins in the input (Inp), supernatant (SN), and pellet (P) samples were separated by
SDS-PAGE. PVDF membrane blotted with protein from WT CITFA7-PTP-expressing cells was probed
with the following primary antibodies: purified polyclonal rat anti-CRK9 antibody to detect CRK9
(negative control), and purified, polyclonal rat anti-CITFA6 antibody to detect CITFA6 (positive control)
[controls in top panel]; purified, polyclonal rat anti-CITFA7 antibody to detect endogenous CITFA7, and
PAP reagent to detect CITFA7-PTP [bottom panel]. Anti-rat IgG POD secondary antibody was used to
detect primary antibodies.
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Knockdown of endogenous CITFA7 leads to increased VSG expression from silent
BESs. Although dimerization may not be the mechanism by which CITFA7 contributes
to monoallelic VSG expression from a single active BES, results from a preliminary semiRT-qPCR on silent VSGs suggested that the putative LC8 binding site mutation
introduced into CITFA7-PTP disrupts monoallelic expression. In particular, after
silencing endogenous CITFA7 with doxycycline (leaving only PTP-tagged CITFA7,
either WT or mutant, expressed), gel electrophoresis images showed elevated expression
of silent VSGs indicated by strong bands in mutant cell lanes but not WT lanes (T.
Nguyen, data not shown). To confirm this initial result both semi-quantitatively and
quantitatively, Mut1, MutX, and WT clones in exponential growth were subjected to a
10d (and in a subsequent trial, 3d) dox treatment. Total RNA was isolated from cells at
the 0d and 10d (or 3d) mark and reverse transcribed. For semi-RT-qPCR, both a single
silent VSG and four silent VSGs (primers were designed taking advantage of regions of
sequence consensus) were amplified. Bands were not visible in both WT and mutant cell
lanes before CITFA7 silencing (0d), despite the fact that half of the CITFA7 proteins
available to mutant cells before silencing are abnormal. However, strong bands in both
Mut1 and MutX clone lanes, indicative of silent VSG expression, were noted after 10d
silencing, while no bands were noted in the WT lanes (Figure 4A). Before proceeding
with RT-qPCR analysis of VSG expression, the quality of the isolated RNA was assessed
by direct detection of rRNA (Lonza ReliantTM Gel System), and the relative
concentrations of cDNA was assessed by RT-qPCR amplifying 18S ribosomal cDNA.
RNA appeared intact, with no streaking or smearing noted in any lanes (Figure 4B).
Meanwhile, abundance of 18S rRNA was consistent between WT Mut1 samples (fold
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range: 1.00-1.19) before and after 10d induction (Figure 4C). RT-qPCR results show that
mRNA abundance of the four normally silent VSGs increased between 10.8-fold in Mut1
cells, and the expression of a single silent VSG increased 13.8-fold, while VSG expression
did not change in WT cells after 10d. Negligible increases in expression level were found
for the active VSG in WT (1.00 to 1.05) and Mut1 (1.00 to 1.322) cells, within the range
of expected experimental variability (Figure 5A-C).

Platt 24

Figure 4 Verification of RNA quality and relative concentrations of cDNA samples. (A) Total RNA
prepared from 0d and 10d-induced cells was reverse transcribed with Oligo-dT and analyzed by semi-RTqPCR with oligonucleotides for four Silent VSGs, a single silent VSG, and the active VSG. (B) Total RNA
separated by ReliantTM precast 1.25% agarose RNA gel and rRNA stained with ethidium bromide. (C) RTqPCR of cDNA (rRNA reverse transcribed with random hexamer) from 0d an 10d-induced cells.

To determine whether the semi-RT and RT-qPCR results could be reproduced
with cells induced over a shorter duration, a 3d induction was carried out. Semi-RTqPCR with 3d cDNA showed qualitatively indistinguishable results from that of the 10d
experiment; Mut1 and MutX lanes showed strong bands after 3d of endogenous CITFA7
silencing (data not shown). Consistent with the 3d semi-RT-qPCR, RT-qPCR results
showed that mRNA abundance of four silent VSGs increased in Mut1 and MutX cells by
6.9-fold and 5.3-fold, respectively, and decreased slightly (1.00 to 0.59) in WT cells
(Figure 4B). At the same time, expression of the active VSG decreased negligibly (WT:
1.00 to 0.76; Mut1: 1.00 to 0.99; MutX: 1.00 to 0.86) in all three cell lines (Figure 4A),
and expression of the single silent VSG increased by 6.2-fold in Mut1 and 6.3-fold in
MutX, respectively, while decreasing minimally (1.00 to 0.71) in WT cells (Figure 4C).
Thus, the quantitative results align with initial semi-quantitative findings that suggested
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that expression mutant CITFA7 in the absence of the WT form disrupts monoallelic VSG
expression.

Figure 5 RT-qPCR analysis of mRNA abundances in 0d and 10d-induced WT and Mut1
trypanosomes, and in 0d and 3d-induced WT, Mut1, and MutX cells (n=2). (A) relative mRNA
abundance of active VSG (B) four silent VSGs (C) and a single silent VSG. mRNA was reverse transcribed
with Oligo-dT.VSG mRNA relative abundance was normalized against that of the housekeeping gene, αtubulin.
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Visualization of CITFA7-PTP within a subnuclear compartment. Given that RTqPCR results showed an increase in expression of VSG from silent BESs following
endogenous CITFA7 silencing, it was expected that mutant CITFA7 might be found in
multiple subnuclear locations within cells in which unmodified CITFA7 upon dox
induction, representing newly activated BESs. RNA pol I has previously been found to
appear brightly around the nucleolar periphery. The associated protein, RPB7-PTP has
also been detected around the perimeter but not within the nucleolus (Park et al., 2011).
Thus, it was expected that CITFA7, a subunit of the RNA pol I transcription-initiation
complex CITFA, might also be detected as a ring, outlining the edge of the nucleolus.
Indirect immunofluorescence was carried out to compare CITFA7 signals 0d and
3d post-induction. A primary polyclonal rabbit anti-ProtA antibody was used to detect the
Protein A domain of the PTP tag on CITFA7, and the constant region of this rabbit
antibody was then detected with Alexa Fluor™ 594 secondary antibody. Contrary to
expectations, preliminary review of images comparing the number of distinct
extranucleolar spots between 0d and 3d induced Mut1 cells did not indicate an increase in
CITFA7-PTP foci after 3d, however, CITFA7-PTP signal appeared noticeably larger
and/or more diffuse in some 3d dox-induced cells, as shown in representative images
(Figure 6A). In multiple cases, CITFA7-PTP in 0d Mut1 cells was detected both
encircling the characteristically dark nucleolus and in a single spot outside of this region
(Figure 6A). While it is possible this extranucleolar signal could represent the ESB, this
pattern was not observed in all Mut1 0d cells, preventing definitive identification of the
ESB. As found in the representative z-stack sequences of a 0d Mut1 cell, CITFA7-PTP
clearly encircled the nucleolus and appeared to be localized in an extranucleolar spot in
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the top left of the cell (Figure 6C). CITFA7-PTP in 3d induced Mut1 cells was also
detected around the perimeter of the nucleolus, though a distinct extranucleolar spot was
not always discernible (Figure 6D). As can be seen in the 3d Mut1 z-stack sequence,
CITFA7-PTP was sometimes detected as multiple distinct spots, as predicted, however it
was unclear whether these spots corresponded to the peripheral nucleolar signal or to an
extranucleolar compartment (Figure 6E). Indirect fluorescence was performed on MutX
and WT cells in addition to Mut1 cells, however, there were unforeseen difficulties in
staining and imaging these two clones, negating analysis (data not shown).
Due to the very small size of the trypanosome nucleolus and the ESB, more
reliable detection of these subnuclear bodies has been achieved by direct fluorescence
microscopy (Nguyen et al., 2014). Thus, to visualize CITFA in our WT and Mut1 cell
lines during endogenous CITFA7 silencing by direct fluorescence microscopy, a preestablished CITFA2-mCherry plasmid was transfected into these cells. Since CITFA2 is
an essential subunit of the CITFA complex and binds directly to BES and rRNA
promoters and given that dox-induced endogenous CITFA7 knockdown seems to
increase expression of silent VSGs, it is expected that CITFA2 will show as multiple
spots within the nucleus after CITFA7 silencing in mutant CITFA7-PTP cells. In a future
study, these cells will be subjected to direct fluorescence microscopy for quantification of
fluorescent signals from the ESB and any other extranucleolar regions to which CITFA2
may be directed.
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Figure 6 Indirect immunofluorescence microscopy of CITFA7-PTP before (A-B) and after (C-D) 3day endogenous CITFA7 silencing. Mut1 CITFA7-PTP strain 427 cells were fixed, and DNA was stained
with DAPI (n, nucleus; k, kinetoplast). The nucleolus is identified with a yellow arrow. Examples were
chosen in which a single or multiple subnuclear spots were visible, and brightness and contrast were
enhanced. CITFA7-PTP was detected with a polyclonal anti-ProtA primary antibody and Alexa Fluor™
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594 secondary antibody (red). Images were captured with a Zeiss Confocal LSM 780 microscope and
processed with Fiji-ImageJ. (A) Representative 0d and 3d-induced Mut1 cells. (B) Single 0d Mut1 cell. (C)
Z-stack of 0d Mut1 cell; voxel depth: 0.587 μm; slices (z)=8. (D) Single 3d Mut1 cell. (E) Z-stack of 3d
Mut 1 cell; voxel depth: 0.322 μm; z=10.

DISCUSSION
Monoallelic VSG expression seems to require functional CITFA7. Transcription
activation at BES promoters has long been proposed as a key regulatory step of
monoallelic expression in trypanosomes. Though studies have identified RAP1 and other
telomere-associated proteins as critical for maintaining low transcription rates and early
attenuation of transcription from silent BES genes, few studies have elucidated the
mechanism by which RNA pol I transcription activation at the active BES occurs (Yang
et al., 2009; Dreesen et al., 2007). A key distinction should be drawn between BES
activation and sustained BES transcription, as all current evidence points towards distinct
mechanisms regulating these steps. Recently, with the characterization of the VSG
exclusion protein, VEX1, whose sequestration was found to monoallelically restrict VSG
expression by preventing transcription of silent VSG genes, this distinction had become
even clearer. VEX1 assembles with a nonsense-mediated-decay helicase ortholog, VEX2,
in an RNA pol I-dependent fashion (Glover et al., 2016). While VEX1 has been found to
localize within a transcription compartment around the SL RNA gene array with RNA
pol II, VEX2 has been found to localize within a transcription compartment with RNA
pol I and the active VSG gene. With super-resolution microscopy and proximity ligation,
these two compartments were found to exist in close spatial proximity, and this closeness
has been hypothesized to supply a high enough concentration of trans-splicing machinery
such that VSG transcripts can be efficiently matured (Faria, et al., 2021). However, the
role of VEX proteins in BES transcription activation is predicated on the presence of the
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CITFA complex within the ESB; given that VEX1 is RNA pol-dependent and that the
CITFA complex is RNA pol-I independent, ESB formation depends on RNA pol I
activity, and CITFA is required for this activity to be initiated. Thus, it seems that
monoallelic BES transcription is primarily determined by CITFA’s activity during
transcription initiation.
In this study, we built upon a preliminary LC8 binding partner prediction and
yeast two-hybrid finding that identified a potential LC8 binding motif in CITFA7, part of
the CITFA complex within the nucleus, as well as semi-RT-qPCR findings that showed
that depletion of endogenous CITFA7 (with only a mutant copy of CITFA7 expressed)
leads to an increase in VSG mRNA abundance from silent BESs. Our findings provide
further quantitative evidence that CITFA7 plays an important role in the proper
functioning of the CITFA complex, since when mutant CITFA7 cells were subject to tenday and later to three-day CITFA7-silencing inductions, VSG mRNA abundance from
silent BES increased 5.3-13.8-fold while active VSG mRNA expression remained stable
in mutant CITFA7-PTP cells. One question this finding raises is how silencing of
unmodified CITFA7 compares to knockdowns of other genes associated with monoallelic
VSG expression. From an RNAi screen for loss-of-exclusion of VSG transcription, VEX1
was identified, and a subsequent knockdown of VEX1 led to an overall expression
increase of 18 previously silent VSGs by > 26-fold (Glover et al., 2016), a result which
could perhaps, in part, be attributed to the spreading out of CITFA. In contrast, when the
high-mobility group box protein, TDP1, which is considered to facilitate RNA pol I
transcription, was depleted, growth arrest occurred rapidly, and chromatin repression was
observed at the actively-transcribing RNA pol I locus in the ESB. Conversely,
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overexpression of TDPI was shown to decondense chromatin of silent BES, likely
disrupting monoallelic VSG expression by facilitating readthrough transcription (ArestoBranco et al., 2019). Compared to VEX1 and TDP1, which influence RNA pol I activity
at BES promoters, knockdown of the telomere-associated protein RAP1 has also been
shown to derepress silent BESs. However, in this case, the expression of formerly silent
VSGs seems to be the result of impairing telomeric silencing rather than directly altering
transcription rates. Given VEX1’s role in establishing the ESB and CITFA’s role in
enabling RNA pol I transcription, the increase in silent VSG mRNA abundance that we
observed after silencing endogenous CITFA7 could be the result of disrupting its
sequestration, causing CITFA to spread out from the ESB and alter the rate of
transcription initiation at silent BESs. Thus, while telomeric silencing clearly plays a key
role in maintaining monoallelic transcription of the active VSG, the establishment of the
active BES appears to be distinctly regulated by RNA pol I transcription-associated
proteins, including CITFA7.
One important consideration in light of our results is that we only examined
abundance of VSG mRNA and not pre-mRNA of expression-site-associated genes. BES
genes are transcribed polycistronically and then trans-spliced, however, the fact that only
the active BES has been found to be linked to the SL RNA gene locus would suggest that
trans-splicing of silent BES genes, including VSG, is not as efficient as it is at the active
BES, causing less efficient production of mature VSG mRNA from these repressed loci
(Günzl, 2010; Faria et al., 2021). However, in contrast to VEX1 silencing, when CITFA7
is mutated, it is possible that ESAGs of silent BESs are being transcribed at even higher
levels than downstream VSG genes in at nonlinear rates, particularly if it is the strict
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localization of CITFA within the ESB that is disrupted by the unmodified CITFA7
knockdown. In this model, RNA pol I has greater access to silent BES promoters with
CITFA now available at these locations, and thus more transcription can occur at the
beginning of the BES. However, the persistent heterochromatin structure of previously
silent BESs may continue to reduce transcription of downstream regions including VSG
genes, which would explain the still-lower mRNA abundances of silent VSGs compared
to the active VSG, as shown by our data (Pandy et al., 2013). Given that ESAGs of BES
are highly conserved (over 90%), it is difficult to design primers that can distinguish
between active and silent BES ESAGs without genetically modifying the ESAGs to
include unique tags (Hertz-Fowler et al., 2008). In future studies, we would like to
investigate abundance of BES promoter proximal ESAG transcripts from silent and active
BES, in addition to VSG mRNA abundance to help clarify the mechanism by which the
CITFA7 mutation alters transcription of VSGs.
CITFA7 does not likely contribute to monoallelic expression through dimerization.
Our hypothesis that CITFA7 dimerizes in vivo derived from clear evidence that CITFA2
dimerizes with LC8 and that such dimerization allows CITFA2 to bind to BES promoters
(Kirkham et al., 2016). Since a preliminary finding predicted a putative LC8 binding site
In CITFA7, we postulated that this motif was important for CITFA7’s role in RNA pol Imediated transcription in vivo. A previous study found that CITFA7 consistently
copurifies with CITFA2 and CITFA6 in sub-stoichiometric amounts, indicating that it is
not essential for the formation or the stability of the complex. This was especially true
when co-purification was achieved using PTP-tagged CITFA subunits, which would
suggest that the PTP tag destabilized CITFA7’s ability to bind to these subunits.
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(Brandenburg et al., 2007). In a separate assay, depletion of CITFA7 in vitro led to the
co-loss of all other subunits except LC8, supporting the alternative hypothesis that
CITFA7 serves a stabilizing function (A. Günzl lab, unpublished). However, fluorescence
microscopy has shown that when CITFA1 is silenced, CITFA3 remains localized within
the ESB. Thus, even without CITFA binding to BES promoter DNA, CITFA3 remained
sequestered, perhaps through an interaction mediated by CITFA7 (Park et al., 2014).
Considering our immunoblot results, if CITFA7 interacted with the CITFA complex as a
dimer, it would be expected that both the tagged and untagged versions of the protein in
the precipitate would be seen in a 1:3 ratio. Yet, this ratio was not observed from co-IP,
and instead, our results strongly suggest that CITFA7, in contrast to preliminary results,
does not dimerize in vivo. In light of this, it is still possible that CITFA7 dimerizes in vivo
and the method of co-IP that was used in this study was simply too harsh for the loweraffinity of CITFA7 to CITFA7-PTP and to other subunits of the CITFA complex. In fact,
a bioinformatics analysis suggested that the LC8 binding motif in CITFA2 has a higher
affinity than the one predicted in CITFA7 (A. Günzl lab, unpublished). Thus, it appears
that while CITFA7 is essential for RNA pol I transcription of rRNA genes and the active
VSG in vivo, a nonlethal putative LC8 binding site specifically interferes with CITFA’s
specificity for the active BES.
The question for which we do not yet have a hypothesis is why the transcription
of silent BESs only increases when the endogenous copy of CITFA7 is completed ablated
through an RNAi knockdown, even though before silencing, half of all the CITFA7 genes
being expressed are the mutant form. In light of this observation, the unmodified CITFA7
seems to have a rescue effect in CITFA7-PTP mutant cells. Because it is unlikely that
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mutant CITFA7 and endogenous CITFA7 are expressed at different levels in non-induced
cells, and furthermore, because the dox-induced knockdown negligibly affected the
mRNA abundance of silent VSGs in WT cells, a non-specific effect due to antibiotic
treatment can be excluded. There are multiple possibilities that could explain the rescue
effect that unmodified CITFA7 seems to have on monoallelic VSG expression. For one,
there could be low affinity dimerization required for ESB localization, and the mutation
of CITFA7 could weaken it such that dimerization is unstable between two mutants, but
interaction still occurs between a mutant and WT CITFA7, and between WT and WT
CITFA7. Moreover, the unmodified CITFA7 could outcompete the mutant CITFA7 in its
association with the CITFA complex, making functional CITFA complexes still available
in sufficient quantities for the characteristically high active VSG transcription. It is also
possible that unmodified CITFA7 might stabilize an unidentified scaffold molecule,
whether protein or RNA, which could lead to CITFA’s enrichment in the ESB. If this
function is impaired in mutant CITFA7, the scaffold molecule might be degraded when
mutant CITFA7 is the only form available, causing the loss of CITFA accumulation in
the ESB and the spreading out of CITFA complexes to silent BESs. Thus, although our
data indicate that CITFA7 does not dimerize, the substitution of five amino acids within a
conserved CITFA7 domain appears to alter CITFA7 such that the CITFA7 complex loses
its specificity for the active VSG gene. This finding strongly indicates that CITFA7 has a
role in restricting VSG expression to a single allele at the level of transcription initiation.
At a spatial level, fluorescent microscopy has shown that the site of active VSG
transcription—the bloodstream expression site—is strictly localized within the expression
site body (Navarro & Gull, 2001). CITFA subunits were previously found to be highly
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enriched in the ESB and the nucleolus, and not detectable in other parts of the nucleus
where silent BESs are located (Nguyen et al., 2014; Nguyen et al., 2012). This
localization pattern remained intact even after CITFA1 (an essential direct DNA-binding
subunit of CITFA) was transiently knocked down, which provided strong evidence that
CITFA is sequestered in these compartments independent from transcription initiation
(Park et al., 2014). In dox-induced cells expressing multiple VSGs at high levels, we
expected to see mutant CITFA7 fluorescence signals in multiple spots throughout the
nucleus and not exclusively within the ESB of the active VSG. This prediction was based
on the hypothesis that the non-lethal mutations in CITFA7 would impair CITFA7’s
function in sequestering or otherwise restricting the location of the CITFA complex.
However, our preliminary fluorescence microscopy images are not, at this point, clear
enough for us to identify the ESB and possible extranucleolar spots of silent BES
compartments. While a single extranucleolar spot was detected in some Mut1 0d doxtreated cells, nonspecific antibody binding in other regions of some cells might explain
cases in which spots were seen throughout and sometimes outside of the nucleus. Our
methods of indirect fluorescence will therefore be refined and optimized before
quantitative analysis can be undertaken.
CONCLUSION
In summary, our co-IP results provide evidence that CITFA7 does not dimerize in
vivo, while our semi-RT-qPCR and RT-qPCR results confirm preliminary findings that a
non-lethal mutation in CITFA7 yields upregulated production of VSG mRNA from silent
BESs when only mutant CITFA7 is available. To our knowledge, this is the first time
expression levels of silent VSGs have been changed through disruption of a subunit in a
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promoter-binding complex, and thus our finding further supports the key role that
activation of BES genes mediated by CITFA plays in establishing monoallelic
expression.
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